COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2018

Jul 12, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2018-07-10

Reporting Person: Dreyer Scott (EVP & Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-07-10	Common Stock	A	16186	—	Acquired	16186	Direct

Footnotes

F1: Reflects the grant of restricted stock units in connection with the reporting person's promotion to Chief Commercial Officer of the issuer. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on July 10, 2019, and the balance of the restricted stock units vest in equal installments every six months (in each case, rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.